-
About
Mass General- Hospital Overview
- Why Mass General
- In the Local & Global Community
- Massachusetts General Physicians Organization
- Multimedia
- News & Events
- Support Mass General
- Conditions
& Treatments- View All Conditions & Treatments
- View by Medical Category:
- Centers
& Services- Care Centers
- Departments
- Anesthesia, Critical Care
& Pain Medicine - Dermatology
- Emergency Medicine
- Imaging
- Medicine
- Molecular Biology
- Neurology
- Neurosurgery
- Obstetrics & Gynecology
- Anesthesia, Critical Care
- Facilities & Amenities
- Patient & Family Services
- Research
- View All Research Centers & Labs
- Research at Mass General
- Research News & Events
-
Clinical
Trials - Education
& Training- View All Fellowships, Residencies & CME
- Specialized Education & Training
- Education & Training Calendar
- Career
Opportunities
Chin-Lee Wu, MD, PhD
- Phone: 617-726-2967
- Departments
- Department of Pathology
Specialties
- Cancer Center
- Parathyroid Tumors
- Kidney Cancer
- Prostate Cancer
- Thyroid Tumors
- Testicular Cancer
- Bladder Cancer
- Adrenal Tumors
- Endocrine Tumors
- Head & Neck Cancers
- Genitourinary Oncology
- Clinical Interests
- Genitourinary pathology
- Head and Neck Pathology
- Locations
- Boston: Massachusetts General Hospital
- Medical Education
- MD, First Military Medical University
- PhD, Medical College of Wisconsin
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Anatomic Pathology, American Board of Pathology
- Gender
- Male
- Foreign Languages
- Chinese
- Patient Age Group
- Adult
- Accepting New Patients
- Yes
Biography
Associate Pathologist
Massachusetts General Hospital
Associate Professor of Pathology
Harvard Medical School
Email: cwu2@partners.org
Research
We are in the process of identifying molecular and genetic changes of urologic cancers that correlate with the cancer disease behaviors, both clinically and pathologically. The long-term goal of these studies is to develop new diagnostic methods and therapeutic regiments for these cancers.
See details at the Wu Lab.
PublicationsBibliography of Chin-Lee Wu via PubMed
Gene-expression signature may signify risk for recurrence, metastasis in prostate cancer
A team led by MGH researchers has identified a genetic signature that may reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer. If confirmed, the genetic risk index also may help distinguish tumors that require aggressive treatment from those that can safely be monitored.
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-2967
Fax: 617-726-7474
- © 2013 Massachusetts General Hospital
- 55 Fruit Street, Boston, MA 02114
- Maps & Directions
- 617-726-2000
- TDD: 617-724-8800
